Nocturnal Labs – Scouting, investing

Scouting, Investing in and Nurturing Healthcare Innovation

Innovative technology platforms based on plant-derived extracellular vesicles for vaccines and wound care therapies

Development of a novel treatment for small abdominal aortic aneurysms.

Nocturnal Labs is an operational industrial holding that invests in companies developing disruptive healthcare products, services and technologies.

NOCTURNAL LABS TEAM

A cumulative 160+ years of experience in the healthcare industry…

SEE OUR COMPANIES

Young, very agile and highly innovative companies burning up with ideas…

LATEST NEWS

dyverto

DYVERTO AG GETS A COMBINED “SEED” FUNDING OF NEARLY 1 MILLION EUROS for the development of a novel treatment for small abdominal aortic aneurysms.

24 August 2022

Dyverto AG, an innovative start-up operating in the vascular sector created by CVLab, announces the entry into the share capital of Davide Bianchi and Nocturnal Labs SpA. The “seed” investment is intended for the development of a device aimed at stopping and potentially reversing the progression of arterial aneurysms. The funds will be used to […]

evobiotech

EVOBIOTECH GETS A “SEED” FUNDING OF € 1 MILLION for the development of new vaccines and therapies based on extracellular vesicles of plant origin

6 August 2021

EvoBiotech, an innovative start-up operating in the biotechnology sector, announces the entry into the share capital of Nocturnal Labs SpA, an Operational Holding Company with a strong innovative vision, and of LuMar. The “seed” investment for a total of € 1 million to EvoBiotech is intended for the development of a project on extracellular vesicles […]